Skip to Main Content

Paper Details

Approaches to identifying drug resistance mechanisms to clinically relevant treatments in childhood rhabdomyosarcoma.
Cancer Drug Resist
3
2022
Mouse, RMS, RMS xenograft models, Tumor, Tumor models, VAC, VAC-resistant models, actinomycin D, childhood rhabdomyosarcoma, cyclophosphamide, metastatic, mice, patients, rhabdomyosarcoma, tumor, tumors, vincristine
Author NameAffiliation
Christopher L MortonSt. Jude Children's Research Hospital
Siyuan ZhengGreehey Children's Cancer Research Institute
Siyuan ZhengGreehey Children's Cancer Research Institute
Raushan T KurmashevaGreehey Children's Cancer Research Institute
Peter J HoughtonGreehey Children's Cancer Research Institute
  • 1 - 5

Datasets

Release 1.2